Metaxalone and Drowsiness - a phase IV clinical study of FDA data

Summary:

Drowsiness is found among people who take Metaxalone, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Metaxalone and have Drowsiness. It is created by eHealthMe based on reports of 3,664 people who have side effects when taking Metaxalone from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On May, 17, 2022

3,664 people reported to have side effects when taking Metaxalone.
Among them, 110 people (3.0%) have Drowsiness.


What is Metaxalone?

Metaxalone has active ingredients of metaxalone. It is often used in back pain - low. eHealthMe is studying from 3,829 Metaxalone users for its effectiveness, alternative drugs and more.

What is Drowsiness?

Drowsiness is found to be associated with 3,908 drugs and 4,284 conditions by eHealthMe.

Number of Metaxalone and Drowsiness reports submitted per year:

Could Metaxalone cause Drowsiness?

Time on Metaxalone when people have Drowsiness *:

Click here to view

Gender of people who have Drowsiness when taking Metaxalone*:

Click here to view

Age of people who have Drowsiness when taking Metaxalone *:

Click here to view

Common drugs people take besides Metaxalone *:

Click here to view

Common side effects people have besides Drowsiness *:

Click here to view

Common conditions people have *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Metaxalone and have Drowsiness?

Check whether Drowsiness is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of Metaxalone:

Drowsiness treatments and more:

COVID vaccines that are related to Drowsiness:

How severe was Drowsiness and when was it recovered:

Expand to all the drugs that have ingredients of metaxalone:

Common drugs associated with Drowsiness:

All the drugs that are associated with Drowsiness:

Common conditions associated with Drowsiness:

All the conditions that are associated with Drowsiness:

How the study uses the data?

The study uses data from the FDA. It is based on metaxalone (the active ingredients of Metaxalone) and Metaxalone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: